Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00052143 · ClinicalTrials.gov registry record
Prospective Huntington At Risk Observational Study
A clinical trial of Huntington Disease, sponsored by Huntington Study Group.
- Completed
- Registry status
- 1,001
- Enrollment target
- 20
- Study locations
NCT00052143 is a study of Huntington Disease that has completed, run by Huntington Study Group. The registered enrollment target is 1,001 participants, above the 607-participant average among 35 other Huntington Disease trials with a reported enrollment target (65% higher). The trial reports 20 study locations across 13 states.
The verdict
NCT00052143, a study of Huntington Disease, has completed, sponsored by Huntington Study Group.
- COMPLETED
- Registry status
- 1,001 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to define the natural history and experiences of people who are at risk for developing Huntington's disease but who do not know their genetic status.
Conditions Studied
Study Locations (20)
California
- University of California at San Diego - La Jolla
- UCLA School of Medicine - Los Angeles
- University of California, Davis - Sacramento
Connecticut
- University of Connecticut - Hartford
- Institute for Neurodegenerative Disorders - New Haven
Florida
- University of Miami School of Medicine - Miami
- University of South Florida - Tampa
Kansas
- University of Kansas Medical Center - Kansas City
- Hereditary Neurological Disease Center - Wichita
Maryland
- Johns Hopkins University - Baltimore
- University of Maryland at Baltimore - Baltimore
Massachusetts
- Boston University School of Medicine - Boston
- Massachusetts General Hospital - Boston
Alabama
- University of Alabama - Birmingham
Arizona
- Mayo Clinic Arizona - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,001 participants |
| Start Date | 1999-07-09 |
| Est. Completion | 2009-12-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00052143
The ClinicalTrials.gov registry entry for NCT00052143 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,001 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 607-participant average among 35 other Huntington Disease trials with a reported enrollment target (65% higher). The listed sponsor is Huntington Study Group, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Huntington Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00052143 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Connecticut, Florida.
Frequently Asked Questions
What is clinical trial NCT00052143 about?
NCT00052143 is a clinical study titled "Prospective Huntington At Risk Observational Study". The purpose of this study is to define the natural history and experiences of people who are at risk for developing Huntington's disease but who do not know their genetic status.
What is the current status of trial NCT00052143?
This trial is currently completed. The enrollment target is 1,001 participants. The study started on 1999-07-09. Estimated completion is 2009-12-17.
What conditions does trial NCT00052143 study?
This clinical trial studies the following conditions: Huntington Disease.
Who is sponsoring clinical trial NCT00052143?
This trial is sponsored by Huntington Study Group, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00052143 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Huntington Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Longitudinal Endpoint Assessment of Disease Burden in HD
RECRUITING
-
Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers
RECRUITING
-
Extracellular Vesicles for HD
RECRUITING
-
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
RECRUITING · Phase 3
-
A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.